Intravesical Injection of Botox for Treating Therapy Refractory Overactive Bladder in Females

University of Zurich200 enrolled

Overview

The neurotoxin Botox (botulinum neurotoxin type A) is shown to be effective in the treatment of therapy refractory overactive bladder syndrome. Our data suggests a longer during efficacy than known from the use in striated muscle. The aim of our study is to analyze short- and longterm efficacy after Botox treatment and to evaluate risk factors for non-responders and side effects such as urinary retention.

Study Type

OBSERVATIONAL

Enrollment

200

Conditions

Overactive Bladder Syndrome

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * intravesical treatment with Botox at our clinic

Locations (1)

University Hospital of Zurich, Clinic for Gynaecology

Zurich, Switzerland

Outcomes

Primary Outcomes

duration of effect of Botox

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.